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1. Introduction
   The global population is projected to rise by 20% from 6.7 billion 
to 8.1 billion by 2030, but the crude death rate is expected to remain 
stable at around 8.4 deaths/thousand. However, a major shift is 
currently underway in the overall disease burden in the world. In 
2008, five out of the top ten causes for mortality worldwide were 
non-communicable diseases (NCDs), which have figured out to 
be seven out of ten by the year 2030 and majority resides in the 
developing countries. It is projected that, by the year 2030, about 
76% of the deaths in the world would be due to NCDs[1].
   Cardiovascular diseases (CVDs) were once thought to be the 
disease impacting the rich and affluent community, but it is 
now well established that they afflict the poor as well[2]. Due to 
urbanization there is a changing trend in lifestyles, blue collar and 
high demanding jobs, unhealthy eating habits and less physical 
activity are the key reasons for high incidence rates in the rich 
population. These diseases not only affect the well being, but can 
also retrain the economic growth of the country due to increased 
healthcare expenditure and diminished productivity. 
   Even there is increasing availability and focus on curative care in 
urban areas, this alone cannot clear up the problem of CVDs. The 
need of the hour is to focus on prevention and its early diagnosis and 
management and it is not that the health care providers alone can 
tackle this problem. There is an urgent need for the urban planners, 
educational institutions, employers, food and beverage industries, 
wellness and fitness players and above all the government policies 
to take up the challenge and work towards behaviour and lifestyle 
changes through positive and negative reinforcements.
   In rural India, it is relatively more complex to solve this 
problem as it needs to create and improve awareness, access and 
affordability to all in the society. The lack of awareness coupled 
with the inadequate access to diagnosis leads to a very large number 
of patients needing tertiary care. The shortage of such high end 
facilities as well as their inability to pay, leads to high mortality 
among the rural population.
   To solve this problem, urgent development is required to cross 
the cardiac value chain and collaboration with health care sectors 
including the Government, pharmaceutical companies, medical 
technology firms and health insurers. Recent developments have 
taken place in this direction, with the Government launching the 
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National NCD programme which would focus on prevention and 
awareness, and sporadic examples of innovations in medical and 
mobile technology that allow early detection and monitoring. 
2. Global prevalence of CVDs
   CVDs comprise of the disorders of the heart and blood vessels and 
commonly include multifactorial heterogenous conditions such as 
hypertension, coronary heart disease (CHD), stroke, congestive heart 
failure, cerebrovascular disease, peripheral arterial disease, rheumatic 
heart disease, deep vein thrombosis and pulmonary embolism. CVDs 
are the leading cause of deaths globally with maximum deaths 
annually. In 2008, CVDs represented 30% (17.3 million) of all deaths 
globally[3]. CHD and stroke accounted for 7.3 million and 6.2 million 
deaths of all the global deaths from CVDs, respectively[4]. The 
projected deaths from CVDs, mainly from heart disease and stroke 
have been estimated to reach 23.3 million by 2030[5].
3. Prevalence of CVDs in Indian subcontinent 
   Eighty percent of CVD related deaths are being reported from low 
and middle income countries like India[3]. The incidence of CVD is 
increasing everyday and 25% of all mortality is due to coronary artery 
disease. Population surveys from India have reported 9-fold increase in 
its prevalence and expected to cause doubling of deaths due to CVD by 
2015 (Figure 1)[6].
Neuropsychiatric conditions
Diabetes mellitus
Digestive diseases
Cancers
Respiratory diseases
Cardiovascular diseases
Others
NCDs
53%37%
10%
370
a.  
b. 
Injuries
19%
NCDs
57%
Communicable
24%
2 333
1 091
648
481
177
142
Injuries
Communicable 
diseases
Figure 1. Prevalence of CVDs in India. 
a: Deaths in 2008 due to CVDs; b: Estimated disease burden in India by 2020.
4. Indians and cardiovascular risk
   The concept of cardiovascular risk factors was first introduced 
in 1961 from the Framingham Heart Study, linking the presence of 
specific parameters like elevated cholesterol, hypertension, diabetes 
mellitus, tobacco use. Asian Indian lineage accounts for over one-
fifth of the world population[7]. Asian Indian phenotype is marked 
by combination of clinical (larger waist-to-hip and waist-to-height 
ratios signalling excess visceral adiposity), biochemical [insulin 
resistance, lower adiponectin and higher C-reactive protein (CRP) 
levels], and metabolic aberrations [raised triglycerides (TGs), low- 
and high-density lipoprotein-cholesterol (HDL-c)][8]. The growing 
prevalence of heart diseases in India can be attributed to presence 
of high lipoprotein, environmental and lifestyle risk factors in 
Indian population[8,9]. Inclinations to metabolic syndrome is 
another important reason for higher incidences of CVD in Indian 
population[8,10].
5. Genetic pre-disposition among Indians in the 
development of CVDs
   Several studies have documented that mutation in specific 
genes result in early development of CVDs. On genetic analysis of 
hyperlipidemic patients a correlation was found in the development 
of CVD due to interaction of inherited hyperlipidemic genes and 
environmental factors like stress, unhealthy diet, smoking and 
sedentary life styles[11].
   Some important CVD associated genetic variants are discussed 
below.
5.1. Lipoprotein associated genes 
5.1.1. Lipoprotein lipase (LPL) gene
   This gene is located on chromosome 8p22. It produces an enzyme 
LPL, which hydrolyses TG rich lipoproteins, thus clearing the latter 
from circulation. The occurrence of four different substitution 
mutations, viz., Gly188Glu, Asn291Ser, Asp9Asn and Ser447Ter has been 
reported in different studies[11]. The Asn291Ser substitution increases 
risk of myocardial infarction and also severity of atherosclerosis[12]. 
According to a meta-analysis, substitutions in Gly188Glu, Asn291Ser 
and Asp9Asn support an atherogenic lipoprotein profile with 
disease risk in heterozygous carriers of Gly188Glu, and borderline 
risk in other two types. However, the Ser447Ter showed an opposite 
trend. For the first three substitutions this differential activity 
on lipoprotein profiles maybe because the mutations occur at 
N terminal end (responsible for the enzyme catalytic activity). 
Contrary to this, Ser447Ter substitution occurs at the C terminal end 
and thus possibly influences uptake of lipoproteins by receptors[13].
   Hypertension is one of the major risk factors for CVDs. LPL 
provides fatty acids (FA) through TG hydrolysis as the energy 
substrate for cardiac cells. A variant X447, in which two amino 
acids are deleted from the C terminal, is more efficient in TG 
hydrolysis thus providing protecting against CVD by sustaining low 
levels of TG and FA. However, in hypertensive individuals with 
the variant X447, even though the TG levels are lower than those 
hypertensives with normal S447, the FA levels are significantly 
higher. Subsequently, an overburden of uncleared FA results in an 
increased risk of CVD[14].
5.1.2. Low density lipoprotein receptor genes (LDLR)
   LDLR gene is located on chromosome 19. Mutation in LDLR gene 
causes familial hypercholesterolemia, which is dose dependent 
autosomal dominant disorder, occurs at less than 60 years of age[15].
Atherosclerosis susceptibility, also known as atherogenic lipoprotein 
phenotype, is closely linked to LDLR locus.
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5.1.3. Apolipoprotein genes 
   Apolipoproteins occur in two isoforms: Apo-48 and Apo-B100. 
The polymorphisms in apoliporotein gene may lead to increased 
risk of CVD. Apo-100 is a principal protein component of low 
density lipoprotein and is responsible for mediating cholesterol 
homeostasis. Four common polymorphisms, identified in its gene 
include: MspI (in codon 3611, amino acid change from arginine 
to glutamine); XbaI (exon 26, A→T in threonine codon, silent 
mutation); EcoRI (exon 29, GAA AAA; 4,154th nucleotide, Glu→ 
Lys); 3’ HVR (multiallelic locus with tandem repeats 11 to 16 bp AT-
rich DNA sequences beginning 73 bp, 3´ to second polyadenylation 
signal).
   The presence of these mutations is correlated significantly with 
unfavorable lipid profiles which include high cholesterol and 
TG levels along with decreased concentrations of high density 
lipoprotein[16].
5.1.4. Apolipoprotein E genes 
   Apolipoprotein E genes play a major role in cholesterol and 
TG metabolism. A common polymorphism in this gene codes for 
3 isoforms E2, E3 and E4 with equivalent allele ε2, ε3 and ε4, 
located on chromosome 19. Studies report that ε4 is associated with 
a slightly higher risk of CVD in both genders[17-19]. 
5.2. Endothelial nitric oxide synthase gene (eNOS) 
   Vascular endothelial dysfunction is a common characteristic 
of various CVDs. The maintenance of vascular homeostasis 
considerably depends on the bioavailability of endothelium-derived 
nitric oxide synthesized by endothelial nitric oxide synthase (eNOS). 
This enzyme has been implicated in pathogenesis of CVD. The 
eNOS variants in the 7q35-q36 region have been investigated for 
their association with CVD, especially hypertension[20].
   The association of eNOS exon 7 Glu298Asp polymorphism with 
high risk for CVD has been reported in North Eastern Indian 
population with homozygous GG wild genotype as predominant 
one[21].
5.3. Myocyte enhancer factor 2 gene (MEF 2) 
   MEF 2 transcription factor plays a major role in regulation of gene 
expression in multiple muscle cell types. Four MEF 2 genes (A, B, 
C, and D) have been identified[11], and the corresponding protein 
is strongly expressed in the coronary artery endothelium. The CVD 
pathogenesis is mediated by a seven amino acid deletion in this 
gene which reduces transcription activation and thus involvement of 
MEF2A signaling pathway[22]. 
5.4. Methylene tetrahydrofolate reductase gene (MTHFR) 
   MTHFR regulates folate-dependent homocysteine remethylation. 
Its deficiency causes hyperhomocysteinemia. Homozygous 677C→T 
mutation in MTHFR gene is associated with premature cardiovascular 
disease risk[23]. 
5.5. CYP11B2 and CYP2D6
   CYP11B2 gene plays a major role in the regulation of renin 
angiotensin system as it encodes for aldosterone synthase enzyme 
responsible for aldosterone synthesis which is a main effecter in 
renin angiotensin system. Any disruption in the genetic loci of this 
enzyme results in enhanced aldosterone synthesis and consequently 
elevated blood pressure which precipitates CVD. Studies 
have documented a significant association between CYP11B2 
polymorphism and essential hypertension in males which may 
consequently lead to CVD[24]. 
6. Risk factors for CVDs: an Indian perspective 
   Conventional risk factors for CVDs are broadly classified into 
two categories: modifiable and non-modifiable[25]. Modifiable risk 
factors can reduce the CVD risk if treated and controlled, while 
nonmodifiable risk factors could not be modified to reduce the CVD 
burden. The existing risk factors were based on three primary criteria: 
high prevalence in different populations; significant independent 
impact on the risk of CVD; and reduced cardiovascular risk with 
treatment and control[9]. The major non-modifiable risk factors for 
CVDs in Indian population include: advancing age, heredity factors 
family history, gender, ethnicity. The major modifiable risk factors 
for CVDs in Indian population includes two major aspects, i.e.: 
modifiable cardiometabolic risk factors (hypertension, dyslipidemia, 
diabetes mellitus, obesity) and modifiable lifestyle risk factors 
(smoking, less physical activity, nutrition, low social economic 
status).
   CVD population groups exhibit a cluster of cardiometabolic risk 
factors, which are linked with a number of modifiable lifestyle risk 
factors (Figure 2). Multiple studies have revealed that modifiable 
risk factors are responsible for a large number of premature deaths 
due to CVD[26].
Figure 2. Causative pathways for CVD[26].
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6.1. Modifiable cardiometabolic risk factors
6.1.1. Hypertension
   Hypertension is a major risk factor for CVDs, including stroke and 
myocardial infarction, and its burden is increasing disproportionately 
in developing countries as they undergo demographic shift. For 
every 20 mmHg systolic or 10 mmHg diastolic increase in resting 
blood pressure there is a two-fold increase in risk of death from 
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ischemic heart disease or stroke. Hypertension has been shown 
to cause decreased vascular fulfilment and endothelial injury[27]. 
Hypertension is considered to occur due to interaction of number 
of factors like anthropometry measurement, lipid profile, dietary 
vitamins, serum antioxidants, lipoprotein (a) and lipid peroxides 
and rise in oxidative stress. Results of a study conducted on 345 
elderly hypertensive South Asian patients aged 56-64 years have 
shown that dietary vitamin intake was higher in hypertensive 
patients compared to normotensive controls. Besides, a significant 
difference was observed in anthropometric variables. The lipid 
profile showed a significant increase in total cholesterol, low 
density lipoproteins-cholesterol (LDL-c), TG in hypertensive 
patients (P<0.001). The serum endogenous antioxidants and 
enzyme antioxidants were also significantly decreased in 
hypertensive patients as compared to normotensive patients[28]. 
Another study was conducted on 86 elderly hypertensive patients 
aged 56-64 years to evaluate ischemia modified albumin as 
prognostic marker of to avoid future coronary complications, which 
showed significantly higher ischemia modified albumin levels 
in hypertensive patients as compared to normotensive controls 
(P<0.001)[29]. The carbonic anhydrase activity in hypertensive 
patients has also been show to be highly significant (P<0.001) as 
compared to that in the healthy controls[30].
6.1.2. Dyslipidemia
   The association between dyslipidemia and CVDs is well 
established and particular among these abnormalities are elevated 
levels of LDL-c main risk factor of CVD. Asians experience 
the major proportion of the worldwide burden of CVD. This 
necessitates proper management of LDL-c, HDL-c and also TG 
subfractions[31-33]. The utility of lipid ratios as predictors of 
future risk of CHD risk in normolipidemic myocardial infarct (MI) 
patients has been documented in published studies. One such 
study compared lipid profile of 1 021 elderly normolipidemic MI 
patients with age/sex matched controls. Total cholesterol, TGs, 
LDL-c and HDL-c were estimated in the study. A significantly 
higher total cholesterol, total cholesterol/HDL-c ratio, TG, LDL-c 
and LDL-c/HDL-c ratio was observed in MI patients as compared to 
healthy controls (P<0.001)[34]. Also, the clinical data is suggestive 
of higher levels of lipid peroxidation markers (malondialdehyde 
and conjugated dienes), antioxidants and inflammatory markers 
in normolipidemic acute myocardial infarction (AMI) patients 
than controls. Results of these studies show the higher levels of 
lipoprotein (a), ceruloplasmin, CRP, fibrinogen, malondialdehyde 
and conjugated dienes whereas lower levels of bilirubin, 
ascorbic acid, uric acid, albumin, superoxide dismutase, catalase, 
glutathione peroxidise and paraoxonase-1 activities AMI patients 
than controls[35,36].
6.1.3. Diabetes mellitus
   One of the main risk factor having distinctive association with 
CHD is diabetes, particularly its predominant form, type 2 diabetes 
mellitus. A two- to four-fold higher risk of developing CHD has 
been documented with diabetics than people without diabetes, and 
CVD accounts for 65%-75% of deaths in people with diabetes. 
   Moreover, the age- and sex-adjusted mortality risk in diabetic 
patients without pre-existing CHD was found to be equal to 
that of non-diabetic individuals with prior MI. These findings 
regarding higher risk of mortality are suggestive of common 
precursors to diabetes and CHD, with following implications that 
insulin resistance, visceral adiposity, and excess inflammation 
are characteristic pathophysiology of thrombogenesis. Besides, a 
complex mix of mechanisms such as oxidative stress, enhanced 
atherogenecity of cholesterol particles, abnormal vascular 
reactivity, increased haemostatic activation, and renal dysfunction 
have been considered as features characteristic of type 2 diabetes 
mellitus that may confer excess risk of CHD. 
   The typical “Asian Indian phenotype” refers to a combination of 
clinical (larger waist-to-hip and waist-to-height ratios indicating 
excess visceral adiposity), biochemical (insulin resistance, lower 
adiponectin, and higher CRP levels) and metabolic abnormalities 
(higher TG, LDL-c/HDL-c) that are more prevalent in individuals of 
South Asian origin and thus inclination of this group for developing 
diabetes and premature CHD. The protective female gender effect 
is lost in diabetic subjects, and women with diabetes are possibly 
more prone to develop coronary artery disease than men with 
diabetes[32,33]. 
6.1.4. Obesity
   Body-mass index (BMI) may not truly reflect obesity in Indians 
as obesity is characterized by higher waist-hip ratios and higher 
body fat percentage at given level of BMI. Non-obese (BMI<25 
kg/m2) Asian Indians with normal waist circumference have 
high CVD risk. The traditional cut-off point of BMI of 25 might 
not define overweight and obesity optimally in Asian Indians as 
they have higher percentage of body fat compared to whites[37]. 
Obesity might act a risk factor for heart failure through different 
mechanisms like increased total blood volume, increased cardiac 
output, left ventricular hypertrophy, left ventricular diastolic 
dysfunction, adipositas cordis[38].
6.2. Modifiable life style risk factors
6.2.1. Smoking
   Smoking is estimated to kill five million people worldwide 
each year[39], and is an established risk factor since 1940s[40]. 
Smoking is estimated to cause nearly 10% of all CVD[41]. The risk 
of developing CVD is higher in female smokers, young men and 
chronic smokers[42].
   There are multiple mechanisms which can contribute to CVD risk 
factors when one is a smoker. It can cause atherosclerosis, vascular 
injury, vascular dysfunction, and thrombosis although the precise 
mechanisms are yet to be unveiled[43]. Cigarette smoking increases 
the incidence of CVD in a dose-dependent manner[44-46], with 
even occasional smoking increasing the risk of CVD[47]. Even the 
risk reduction is documented by long-term prospective studies by 
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cessation of smoking[48]. Study conducted by Kumar and Biswas 
on evaluation of parameters associated with CVD in smoker and 
non-smoker showed a highly significant decrease in paraoxonase 
activity[49], antioxidant status and elevation of lipid peroxides 
among smokers which are associated with cardiovascular risks.
6.2.2. Physical activity
   Physical inactivity is responsible for almost 12% of the global 
burden of myocardial infarction[50]. The relative risk of CVD 
is reduced in regular physical activity[51-56]. Study conducted 
and reported from thirteen cities in India by Shah and Mathur 
(2010) showed lower physical activity among both sexes of urban 
population compared to rural ones[57]. The American College of 
Sports Medicine recommends at least 30 min of moderate-intensity 
physical activity for at least 5 d a week[58]. 
6.2.3. Nutrition
   Poor dietary habits affect multiple cardiovascular risk factors 
including blood pressure, cholesterol levels, glucose levels, and 
obesity[59-65]. A diet high in nutrient rich (vitamins, minerals, 
antioxidants and fibre) fruits and vegetables can reduce the risk 
for many leading causes of death[59-65]. In meta-analyses of 
prospective cohort studies, each daily serving of fruits or vegetables 
was associated with a 4% lower risk of CHD (RR 0.96, 95% CI: 
0.93 to 0.99) and a 5% lower risk of stroke (RR: 0.95, 95% CI: 0.92 
to 0.97)[59,60]. Five or more daily servings of fruits and vegetables 
are recommended for optimal nutrition[60,61]. In a study conducted 
by Kumar et al. (2010), where the goal of the study was to address 
the association between dietary vitamin and cardiovascular risk in 
normolipidemic acute MI patients compared with healthy controls. 
The study observed that dietary intake of vitamin A, B1, B2, B3 was 
significantly higher in AMI patients compared to healthy controls 
but the intake of vitamin C was significantly higher in controls 
compared to AMI patients. Even though the vitamins intake was 
higher in patients, the associated cardiovascular risk factors were 
not reduced compared to controls. The study further concluded 
that diets rich in vegetables and fruits do not seem to reduce the 
cardiovascular risk in normolipidemic AMI patients[66].
7. Overall outlook
   There are more than 1.27 billion people across India. More than 
50% of the current Indian population is below age of 25 years and 
65% is below 35 years. About 72.2% of the population lives in 
some 638 000 villages and the rest 27.8% in about 5 480 towns and 
urban agglomerations. Apart from India, indigenous population is 
distributed in 70 countries worldwide, in India there is a significant 
variation between and within peoples in terms of education, 
socioeconomic status, living conditions, and familial factors. In 
spite of diversity, they do share a striking commonality but there is a 
discrepancy in life expectancy. A higher prevalence of CVD may be 
considered the driving force behind this discrepancy, which is being 
aggravated by their lifestyle and subsequent cardiometabolic risk 
factors among them.
   The populations from each of the states ranging from urban to 
rural and semi-rural with age group varying from 25 years to 65 
years exhibits a cluster of cardiometabolic conditions. Most of them 
share common factors like higher rates of obesity and diabetes, 
hypertension and high cholesterol is greater among the urban 
population compared to the rural ones. While each of these factors 
have been reported to be independently associated to enhance 
the risk of CVD, the effects are also thought to be additive. Poor 
lifestyle choices, lack of awareness among rural community might 
herald and contribute to these cardiometabolic outcomes. 
   While smoking rates have fallen among Indian men, they have 
risen among women. Smoking can be attributed to rising cases of 
infertility and higher risk of cancer among Indian women these 
days in addition to cardiovascular risk. Research study examined 
the prevalence of smoking in 187 countries between 1980 and 2012 
and found that while cigarette smoking among Indian men has 
fallen from 33.8% in 1980 to 23% in 2012, it has risen from 3% to 
3.2% among Indian women within the same time frame. In other 
words, the number of female smokers in India has doubled from 
about 5.3 million to 12.2 million in the same period of time. This 
trend is more visible in the urban areas as; women in rural areas 
have the trend of consuming smokeless tobacco in large numbers. 
Compared to other countries, Indians also exhibit dangerous alcohol 
consumption behaviour, as well as lower consumption of fruits and 
green leafy vegetables.
   Other factors include sedentary life styles especially among urban 
population. 
   Holistic strategies which delineate the interactions between 
lifestyle factors might help in promoting positive changes among 
the people who are at risk. Recently published systematic review 
reported that physical activity interventions have only small effect 
on children’s overall activity. Lifestyle changes and strategies to 
inculcate more of physical activities should be linked up with daily 
physical activity as well as lifestyle factors, including nutrition 
and sleep behaviour each of which may be influenced by increased 
physical activity levels and may affect cardiometabolic outcomes.
   In order to maximize potential positive outcomes, strategies which 
aim to promote positive changes in lifestyle should not only be 
physiologically appropriate; they should also be sensitive to socio-
cultural norms. 
   The strategies implemented to promote lifestyle changes must 
be specific to a group or an individual and not to the population 
as a whole, especially when a geographical area includes different 
language and culturally distinct groups. Diversity competence 
involves knowledge, skills, and abilities that enable a researcher to 
deal with a specific population.
   Since we are heading towards middle of 21st century, we need to 
be cautioned and alarmed of the prevailing risk factors existing in 
our society and the message should be disseminated to all through 
social media so that the community and individuals should not be 
ignorant of the strategies to maintain a disease free and a healthy 
livelihood.
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